Positron Emission Tomography in Prostate Cancer

Inclusion Criteria

• •Newly diagnosed prostate cancer
• •Has completed conventional staging examinations, including biopsy with Gleason score, CT scan of the abdomen and pelvis, and whole-body bone scintigraphy AND conventional staging examinations negative
• •Candidate for curative radical prostatectomy OR curative radiotherapy OR staging lymphadenectomy prior to surgery
• •Deemed to be at medium or high risk for recurrence after initial curative treatment, as defined by 1 of the following criteria:
• •* Gleason score 7 AND prostate-specific antigen (PSA) 10-20 ng/mL
• •* Gleason score ≥ 8 AND PSA \< 10 ng/mL
• •* Gleason score ≥ 8 AND PSA \> 10 ng/mL
• •* Any Gleason score AND PSA \> 20 ng/mL
• •Exclusion Therapy:
• •Not a candidate for treatment by surgery or radiation therapy with curative intent
• •Inability to give informed consent
• •Patients with other invasive malignancies, with the exception of non-melanoma skin cancer, who had (or have) any evidence of other cancer present within the last 5 years